首页 › 基金 › Vitruvian Partners LLP › HNGE
Vitruvian Partners LLP 对 HNGE 的持仓历史
HINGE HEALTH INC · 科技
Vitruvian Partners LLP 在 Q3 2026 的 13F 申报中披露持有 HNGE(HINGE HEALTH INC)450,000 股,市值约 US$43.8M,约占其申报组合的 38.62%,在其申报持仓中市值排名第 1 位。 Vitruvian Partners LLP 最近 6 个申报季度中有 6 个季度披露了 HNGE 持仓,最早可追溯至 Q2 2025。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
Vitruvian Partners LLP 对 HNGE 的持仓演变
Vitruvian Partners LLP 于 Q2 2025 首次披露 HNGE 持仓:1,250,000 股(约 US$64.7M)。 在 6 次申报中,Vitruvian Partners LLP 0 次增持、2 次减持、3 次保持不变。 最近一期申报(Q3 2026)显示持股 450,000 股、市值约 US$43.8M,环比减持 -56,599 股。。 持仓曾出现大幅变动:Q2 2026 减持约 59% (随后一个季度股价上涨 17%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2025 | 1.25M | $64.69M | 新进 |
| Q3 2025 | 1.25M | $61.35M | 持有 |
| Q4 2025 | 1.25M | $58.06M | 持有 |
| Q1 2026 | 1.25M | $48.20M | 持有 |
| Q2 2026 | 506.60K | $42.05M | 减持 |
| Q3 2026 | 450.00K | $43.76M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 HNGE 与 13F 数据
HNGE(HINGE HEALTH INC)属于科技行业。我们追踪的基金中还有 100 只申报持有 HNGE,申报仓位最大的包括:11.2 Capital Management, LLC (US$204.6M), Deer Management Co. LLC (US$158.4M), BIT Capital GmbH (US$119.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 HNGE 的基金
- 11.2 Capital Management, LLC 2.46M 股 · $204.57M · Q2 2026
- Deer Management Co. LLC 1.91M 股 · $158.42M · Q2 2026
- BIT Capital GmbH 1.22M 股 · $118.97M · Q3 2026
- BRAIDWELL LP 1.33M 股 · $110.40M · Q2 2026
- Divisadero Street Capital Management, LP 1.29M 股 · $107.12M · Q2 2026
- Walleye Capital LLC 1.27M 股 · $105.21M · Q2 2026
- OBERWEIS ASSET MANAGEMENT INC/ 855.48K 股 · $71.00M · Q2 2026
- Shannon River Fund Management LLC 561.22K 股 · $46.58M · Q2 2026
- Tyro Capital Management LLC 435.61K 股 · $42.36M · Q3 2026
- RTW INVESTMENTS, LP 500.00K 股 · $41.50M · Q2 2026
- EMERALD ADVISERS, LLC 360.05K 股 · $35.01M · Q3 2026
- Estuary Capital Management LP 393.27K 股 · $32.64M · Q2 2026
更多关于 Vitruvian Partners LLP
常见问题
How long has Vitruvian Partners LLP held HNGE?
Vitruvian Partners LLP has disclosed HNGE holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
What is Vitruvian Partners LLP's current position in HNGE?
As of Q3 2026, Vitruvian Partners LLP holds 450.00K shares of HNGE (HINGE HEALTH INC), valued at $43.76M, representing 38.62% of its reported portfolio and ranking #1.
Has Vitruvian Partners LLP been buying or selling HNGE?
In the latest 13F filing (Q3 2026), Vitruvian Partners LLP reduced its position in HNGE.
Which other funds hold HNGE?
Other major institutional holders of HNGE include 11.2 Capital Management, LLC, Deer Management Co. LLC, BIT Capital GmbH, among 100 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.